UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE
COMMISSION

Washington, D.C. 20549

 OMB Number:  3235-0582
 Expires:  January 31, 2015
 Estimated average burden
 hours per response........9.6

 

 

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number 811- 04889

 

H&Q Healthcare Investors

(Exact name of registrant as specified in charter)

 

2 Liberty Square, 9th Floor, Boston, MA

 

02109

(Address of principal executive offices)

 

(Zip code)

 

Laura Woodward

H&Q Healthcare Investors

2 Liberty Square, 9th Floor, Boston MA 02109

(Name and address of agent for service)

 

Registrant’s telephone number, including area code: 617-772-8500

 

Date of fiscal year end: September 30

 

Date of reporting period: 7/1/12-6/30/13

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss.239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 

 

 


 

Item 1. Proxy Voting Record.

 


 

Vote Summary

 

A.P. PHARMA, INC.

 

Security

00202J203

Meeting Type

Annual

Ticker Symbol

APPA

Meeting Date

12-Jun-2013

Record Date

03-May-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

KEVIN TANG

 

 

 

For

 

For

 

 

 

2

STEPHEN R. DAVIS

 

 

 

For

 

For

 

 

 

3

B.D. QUART, PHARM. D.

 

 

 

For

 

For

 

 

 

4

ROBERT ROSEN

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF OUM & CO. LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED PURSUANT TO ITEM 402 OF REGULATION S-K, INCLUDING THE COMPENSATION TABLES AND NARRATIVE DISCUSSION.

 

Management

 

For

 

For

 

4.

 

TO RECOMMEND, IN A NON-BINDING VOTE, THE FREQUENCY OF ADVISORY VOTES TO APPROVE THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

1 Year

 

For

 

 


 

ACCURAY INCORPORATED

 

Security

004397105

Meeting Type

Annual

Ticker Symbol

ARAY

Meeting Date

30-Nov-2012

Record Date

05-Oct-2012

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: ELIZABETH DAVILA

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: JOSHUA H. LEVINE

 

Management

 

For

 

For

 

2

 

ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS (SAY-ON-PAY VOTE).

 

Management

 

For

 

For

 

3

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF TOTAL AUTHORIZED SHARES FROM 105,000,000 TO 205,000,000 AND THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 100,000,000 TO 200,000,000.

 

Management

 

For

 

For

 

4

 

TO RATIFY THE APPOINTMENT OF GRANT THORNTON LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2013.

 

Management

 

For

 

For

 

 

ACORDA THERAPEUTICS, INC.

 

Security

00484M106

Meeting Type

Annual

Ticker Symbol

ACOR

Meeting Date

30-May-2013

Record Date

02-Apr-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

PEDER K. JENSEN, M.D.

 

 

 

For

 

For

 

 

 

2

JOHN P. KELLEY

 

 

 

For

 

For

 

 

 

3

SANDRA PANEM, PH.D.

 

 

 

For

 

For

 

 


 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

AN ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

 

ACTAVIS, INC.

 

Security

00507K103

Meeting Type

Annual

Ticker Symbol

ACT

Meeting Date

10-May-2013

Record Date

15-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: JACK MICHELSON

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: RONALD R. TAYLOR

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: ANDREW L. TURNER

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: PAUL M. BISARO

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: CHRISTOPHER W. BODINE

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: MICHEL J. FELDMAN

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: FRED G. WEISS

 

Management

 

For

 

For

 

2.

 

TO APPROVE, ON AN ADVISORY BASIS, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

 


 

4.

 

TO VOTE ON A PROPOSAL SUBMITTED BY A STOCKHOLDER TO REQUEST THAT THE COMPANY ADOPT A POLICY REQUIRING ITS SENIOR EXECUTIVES TO RETAIN A SIGNIFICANT PERCENTAGE OF THE COMPANY SHARES THEY ACQUIRE THROUGH THE COMPANY’S EQUITY COMPENSATION PROGRAMS UNTIL REACHING RETIREMENT AGE.

 

Shareholder

 

Against

 

For

 

 

AETNA INC.

 

Security

00817Y108

Meeting Type

Annual

Ticker Symbol

AET

Meeting Date

17-May-2013

Record Date

15-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: FERNANDO AGUIRRE

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: MARK T. BERTOLINI

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: FRANK M. CLARK

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: BETSY Z. COHEN

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: MOLLY J. COYE, M.D.

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: ROGER N. FARAH

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: BARBARA HACKMAN FRANKLIN

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: JEFFREY E. GARTEN

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: ELLEN M. HANCOCK

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: RICHARD J. HARRINGTON

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: EDWARD J. LUDWIG

 

Management

 

For

 

For

 

 


 

1L.

 

ELECTION OF DIRECTOR: JOSEPH P. NEWHOUSE

 

Management

 

For

 

For

 

2.

 

APPROVAL OF THE APPOINTMENT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Management

 

For

 

For

 

3.

 

APPROVAL OF THE PROPOSED AMENDMENT TO THE AMENDED AETNA INC. 2010 STOCK INCENTIVE PLAN

 

Management

 

For

 

For

 

4.

 

APPROVAL OF THE COMPANY’S EXECUTIVE COMPENSATION ON A NON-BINDING ADVISORY BASIS

 

Management

 

For

 

For

 

5.

 

SHAREHOLDER PROPOSAL ON INDEPENDENT BOARD CHAIR

 

Shareholder

 

For

 

Against

 

6.

 

SHAREHOLDER PROPOSAL ON SIMPLE MAJORITY VOTE

 

Shareholder

 

Against

 

For

 

7.

 

SHAREHOLDER PROPOSAL ON POLITICAL CONTRIBUTIONS - BOARD OVERSIGHT

 

Shareholder

 

Against

 

For

 

 

AKORN, INC.

 

Security

009728106

Meeting Type

Annual

Ticker Symbol

AKRX

Meeting Date

03-May-2013

Record Date

08-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOHN N. KAPOOR, PHD

 

 

 

For

 

For

 

 

 

2

RONALD M. JOHNSON

 

 

 

For

 

For

 

 

 

3

BRIAN TAMBI

 

 

 

For

 

For

 

 

 

4

STEVEN J. MEYER

 

 

 

For

 

For

 

 

 

5

ALAN WEINSTEIN

 

 

 

For

 

For

 

 

 

6

KENNETH S. ABRAMOWITZ

 

 

 

For

 

For

 

 

 

7

ADRIENNE L. GRAVES, PHD

 

 

 

For

 

For

 

 


 

2.

 

PROPOSAL TO RATIFY THE SELECTION OF KPMG LLP TO SERVE AS AKORN’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

SAY ON PAY - AN ADVISORY VOTE ON APPROVAL OF THE COMPANY’S EXECUTIVE COMPENSATION PROGRAM.

 

Management

 

For

 

For

 

 

ALERE INC.

 

Security

01449J105

Meeting Type

Annual

Ticker Symbol

ALR

Meeting Date

11-Jul-2012

Record Date

17-May-2012

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CAROL R. GOLDBERG

 

 

 

For

 

For

 

 

 

2

JAMES ROOSEVELT, JR.

 

 

 

For

 

For

 

 

 

3

RON ZWANZIGER

 

 

 

For

 

For

 

2

 

APPROVAL OF AN AMENDMENT TO ALERE INC.`S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO DECLASSIFY THE BOARD OF DIRECTORS.

 

Management

 

For

 

For

 

3

 

APPROVAL OF AN INCREASE TO THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE UNDER THE ALERE INC. 2010 STOCK OPTION AND INCENTIVE PLAN BY 2,000,000, FROM 3,153,663 TO 5,153,663.

 

Management

 

For

 

For

 

4

 

APPROVAL OF THE GRANTING OF OPTIONS UNDER OUR 2010 STOCK OPTION AND INCENTIVE PLAN TO CERTAIN EXECUTIVE OFFICERS; PROVIDED THAT, EVEN IF THIS PROPOSAL IS APPROVED BY OUR STOCKHOLDERS, WE DO NOT INTEND TO IMPLEMENT THIS PROPOSAL UNLESS PROPOSAL 3 IS ALSO APPROVED.

 

Management

 

For

 

For

 

 


 

5

 

RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2012.

 

Management

 

For

 

For

 

6

 

APPROVAL, BY NON-BINDING VOTE, OF EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

 

ALEXION PHARMACEUTICALS, INC.

 

Security

015351109

Meeting Type

Annual

Ticker Symbol

ALXN

Meeting Date

06-May-2013

Record Date

11-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LEONARD BELL

 

 

 

For

 

For

 

 

 

2

MAX LINK

 

 

 

For

 

For

 

 

 

3

WILLIAM R. KELLER

 

 

 

For

 

For

 

 

 

4

JOSEPH A. MADRI

 

 

 

For

 

For

 

 

 

5

LARRY L. MATHIS

 

 

 

For

 

For

 

 

 

6

R. DOUGLAS NORBY

 

 

 

For

 

For

 

 

 

7

ALVIN S. PARVEN

 

 

 

For

 

For

 

 

 

8

ANDREAS RUMMELT

 

 

 

For

 

For

 

 

 

9

ANN M. VENEMAN

 

 

 

For

 

For

 

2.

 

APPROVAL OF A NON-BINDING ADVISORY VOTE OF THE 2012 COMPENSATION PAID TO ALEXION’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

 


 

3.

 

APPROVAL OF THE AMENDED AND RESTATED 2004 INCENTIVE PLAN, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT, INCLUDING TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE BY 12 MILLION SHARES (SUBJECT TO ADJUSTMENT IN THE EVENT OF STOCK SPLITS AND OTHER SIMILAR EVENTS).

 

Management

 

For

 

For

 

4.

 

RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS ALEXION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

 

ALKERMES PLC

 

Security

G01767105

Meeting Type

Annual

Ticker Symbol

ALKS

Meeting Date

01-Aug-2012

Record Date

15-Jun-2012

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

FLOYD E. BLOOM

 

 

 

For

 

For

 

 

 

2

GERALDINE A. HENWOOD

 

 

 

For

 

For

 

2.

 

TO APPROVE AN AMENDMENT TO THE ALKERMES PLC 2011 STOCK OPTION AND INCENTIVE PLAN TO INCREASE THE SHARES AVAILABLE FOR ISSUANCE FROM 8,350,000 TO 12,550,000.

 

Management

 

For

 

For

 

3.

 

TO HOLD A NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4.

 

TO HOLD A NON-BINDING ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION.

 

Management

 

1 Year

 

For

 

 


 

5.

 

TO AUTHORIZE HOLDING THE 2013 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY AT A LOCATION OUTSIDE OF IRELAND.

 

Management

 

For

 

For

 

6.

 

TO APPOINT PRICEWATERHOUSECOOPERS AS THE INDEPENDENT AUDITORS OF THE COMPANY AND TO AUTHORIZE THE AUDIT AND RISK COMMITTEE OF THE BOARD OF DIRECTORS TO SET THE AUDITOR’S REMUNERATION.

 

Management

 

For

 

For

 

 

ALLERGAN, INC.

 

Security

018490102

Meeting Type

Annual

Ticker Symbol

AGN

Meeting Date

30-Apr-2013

Record Date

06-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A

 

ELECTION OF DIRECTOR: DAVID E.I. PYOTT

 

Management

 

For

 

For

 

1B

 

ELECTION OF DIRECTOR: MICHAEL R. GALLAGHER

 

Management

 

For

 

For

 

1C

 

ELECTION OF DIRECTOR: DEBORAH DUNSIRE, M.D.

 

Management

 

For

 

For

 

1D

 

ELECTION OF DIRECTOR: DAWN HUDSON

 

Management

 

For

 

For

 

1E

 

ELECTION OF DIRECTOR: TREVOR M. JONES, PH.D.

 

Management

 

For

 

For

 

1F

 

ELECTION OF DIRECTOR: LOUIS J. LAVIGNE, JR.

 

Management

 

For

 

For

 

1G

 

ELECTION OF DIRECTOR: PETER J. MCDONNELL, M.D.

 

Management

 

For

 

For

 

1H

 

ELECTION OF DIRECTOR: TIMOTHY D. PROCTOR

 

Management

 

For

 

For

 

1I

 

ELECTION OF DIRECTOR: RUSSELL T. RAY

 

Management

 

For

 

For

 

2

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Management

 

For

 

For

 

 


 

3

 

ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS

 

Management

 

For

 

For

 

4

 

APPROVE THE AMENDMENT AND RESTATEMENT OF OUR AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

5.1

 

STOCKHOLDER PROPOSAL #1 - RIGHT TO ACT BY WRITTEN CONSENT

 

Shareholder

 

Against

 

For

 

5.2

 

STOCKHOLDER PROPOSAL #2 - DISCLOSURE OF LOBBYING PRACTICES

 

Shareholder

 

For

 

Against

 

 

AMARIN CORPORATION PLC

 

Security

023111206

Meeting Type

Annual

Ticker Symbol

AMRN

Meeting Date

09-Jul-2013

Record Date

22-Apr-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

O1

 

TO RE-ELECT MR. JOSEPH S. ZAKRZEWSKI AS A DIRECTOR

 

Management

 

For

 

For

 

O2

 

TO RE-ELECT MS. KRISTINE PETERSON AS A DIRECTOR

 

Management

 

For

 

For

 

O3

 

TO ELECT MR. DAVID STACK AS A DIRECTOR

 

Management

 

For

 

For

 

O4

 

TO HOLD AN ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF THE COMPANY’S “NAMED EXECUTIVE OFFICERS” AS DESCRIBED IN THE COMPENSATION DISCUSSION AND ANALYSIS SECTION, THE TABULAR DISCLOSURE REGARDING SUCH COMPENSATION, AND THE ACCOMPANYING NARRATIVE DISCLOSURE SET FORTH IN THE ENCLOSED PROXY STATEMENT

 

Management

 

For

 

For

 

 


 

O5

 

TO HOLD AN ADVISORY (NON-BINDING) VOTE TO APPROVE THE DIRECTORS’ REMUNERATION REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012

 

Management

 

For

 

For

 

O6

 

TO APPOINT DELOITTE & TOUCHE LLP AS AUDITORS TO HOLD OFFICE UNTIL THE CONCLUSION OF THE NEXT GENERAL MEETING AT WHICH ACCOUNTS ARE LAID BEFORE THE COMPANY AND TO AUTHORIZE THE AUDIT COMMITTEE OF BOARD OF DIRECTORS TO FIX AUDITORS’ REMUNERATION

 

Management

 

For

 

For

 

S7

 

TO AMEND THE COMPANY’S ARTICLES OF ASSOCIATION TO REMOVE A BORROWING LIMITATION ON THE COMPANY BY DELETING ARTICLES 143(B) TO (E) (INCLUSIVE)

 

Management

 

For

 

For

 

 

AMGEN INC.

 

Security

031162100

Meeting Type

Annual

Ticker Symbol

AMGN

Meeting Date

22-May-2013

Record Date

25-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: DR. DAVID BALTIMORE

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: MR. FRANK J. BIONDI, JR.

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: MR. ROBERT A. BRADWAY

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: MR. FRANCOIS DE CARBONNEL

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: DR. VANCE D. COFFMAN

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: MR. ROBERT A. ECKERT

 

Management

 

For

 

For

 

 


 

1G.

 

ELECTION OF DIRECTOR: DR. REBECCA M. HENDERSON

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: MR. FRANK C. HERRINGER

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: DR. TYLER JACKS

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: DR. GILBERT S. OMENN

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: MS. JUDITH C. PELHAM

 

Management

 

For

 

For

 

1L.

 

ELECTION OF DIRECTOR: MR. LEONARD D. SCHAEFFER

 

Management

 

For

 

For

 

1M.

 

ELECTION OF DIRECTOR: DR. RONALD D. SUGAR

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

ADVISORY VOTE TO APPROVE OUR EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

APPROVAL OF OUR PROPOSED AMENDED AND RESTATED 2009 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

 

ANTISOMA PLC

 

Security

03248123

Meeting Type

Annual

Ticker Symbol

ASM.L

Meeting Date

25-Oct-2012

Record Date

n/a

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO RECEIVE AND ADOPT THE DIRECTORS REPORT.

 

Management

 

For

 

For

 

2.

 

RE-ELECT MICHAEL BRETHERTON.

 

Management

 

For

 

For

 

3.

 

RE-ELECT JONATHAN MORLEY-KIRK.

 

Management

 

For

 

For

 

 


 

4.

 

TO RE-APPOINT PRICEWATERHOUSECOOPERS LLP AS AUDITORS OF THE COMPANY AND TO AUTHORISE THE DIRECTORS TO DETERMINE THEIR RENUMERATION YOUNG LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

Management

 

For

 

For

 

5.

 

TO AUTHORISE THE DIRECTORS TO DETERMINE THE AUDITOR’S FEES.

 

Management

 

For

 

For

 

6.

 

TO AUTHORISE THE DIRECTORS TO ALLOT SHARES.

 

Management

 

For

 

For

 

7.

 

TO AUTHORISE THE DISAPPLICATION OF STATUTORY PRE-EMPTION RIGHTS.

 

Management

 

For

 

For

 

 

ARIAD PHARMACEUTICALS, INC.

 

Security

04033A100

Meeting Type

Annual

Ticker Symbol

ARIA

Meeting Date

20-Jun-2013

Record Date

25-Apr-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ATHANASE LAVIDAS, PH.D

 

 

 

For

 

For

 

 

 

2

MASSIMO RADAELLI, PH.D.

 

 

 

For

 

For

 

2.

 

TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 240 MILLION TO 450 MILLION SHARES.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2013.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

 


 

BAXTER INTERNATIONAL INC.

 

Security

071813109

Meeting Type

Annual

Ticker Symbol

BAX

Meeting Date

07-May-2013

Record Date

11-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: THOMAS F. CHEN

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: BLAKE E. DEVITT

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: JOHN D. FORSYTH

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: GAIL D. FOSLER

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: CAROLE J. SHAPAZIAN

 

Management

 

For

 

For

 

2.

 

RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Management

 

For

 

For

 

3.

 

APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION

 

Management

 

For

 

For

 

4.

 

AMENDMENT OF ARTICLE SIXTH OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ELIMINATING THE CLASSIFIED STRUCTURE OF THE BOARD OF DIRECTORS

 

Management

 

For

 

For

 

5.

 

AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION GRANTING HOLDERS OF AT LEAST 25% OF OUTSTANDING COMMON STOCK THE RIGHT TO CALL A SPECIAL MEETING OF SHAREHOLDERS

 

Management

 

For

 

For

 

 


 

BIOGEN IDEC INC.

 

Security

09062X103

Meeting Type

Annual

Ticker Symbol

BIIB

Meeting Date

12-Jun-2013

Record Date

15-Apr-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: CAROLINE D. DORSA

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: STELIOS PAPADOPOULOS

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: GEORGE A. SCANGOS

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: LYNN SCHENK

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: ALEXANDER J. DENNER

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: NANCY L. LEAMING

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: RICHARD C. MULLIGAN

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: ROBERT W. PANGIA

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: BRIAN S. POSNER

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: ERIC K. ROWINSKY

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: STEPHEN A. SHERWIN

 

Management

 

For

 

For

 

1L.

 

ELECTION OF DIRECTOR: WILLIAM D. YOUNG

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS BIOGEN IDEC INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

SAY ON PAY - AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

TO REAPPROVE THE MATERIAL TERMS OF THE PERFORMANCE GOALS UNDER THE BIOGEN IDEC INC. 2008 PERFORMANCE- BASED MANAGEMENT INCENTIVE PLAN FOR PURPOSES OF SECTION 162(M) OF THE INTERNAL REVENUE CODE.

 

Management

 

For

 

For

 

5.

 

TO REAPPROVE THE MATERIAL TERMS OF THE PERFORMANCE GOALS UNDER THE BIOGEN IDEC INC. 2008 OMNIBUS EQUITY PLAN FOR PURPOSES OF SECTION 162(M) OF THE INTERNAL REVENUE CODE.

 

Management

 

For

 

For

 

6.

 

SHAREHOLDER PROPOSAL REGARDING ADOPTION OF A SHARE RETENTION POLICY.

 

Shareholder

 

Against

 

For

 

 


 

CARDIOKINETIX, INC.

 

Security

N/A

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

Meeting Date

18-Feb-2013

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

CERTIFICATE OF AMENDEMNT OF SIXTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

2.

 

APPROVE THE AMENDEMENT OF THE 2011 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF COMMON STOCK RESERVED FOR ISSUANCE BY 972,677.

 

Management

 

For

 

For

 

3.

 

GENERAL AUTHORIZING RESOLUTION.

 

Management

 

For

 

For

 

 

CARDIOKINETIX, INC.

 

Security

N/A

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

Meeting Date

14-Dec-2012

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

ADOPT AND APPROVE THE AMENDMENT TO THE CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

2.

 

GENERAL AUTHORIZING RESOLUTION.

 

Management

 

For

 

For

 

 


 

CELGENE CORPORATION

 

Security

151020104

Meeting Type

Annual

Ticker Symbol

CELG

Meeting Date

12-Jun-2013

Record Date

17-Apr-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT J. HUGIN

 

 

 

For

 

For

 

 

 

2

R.W. BARKER, D. PHIL.

 

 

 

For

 

For

 

 

 

3

MICHAEL D. CASEY

 

 

 

For

 

For

 

 

 

4

CARRIE S. COX

 

 

 

For

 

For

 

 

 

5

RODMAN L. DRAKE

 

 

 

For

 

For

 

 

 

6

M.A. FRIEDMAN, M.D.

 

 

 

For

 

For

 

 

 

7

GILLA KAPLAN, PH.D.

 

 

 

For

 

For

 

 

 

8

JAMES J. LOUGHLIN

 

 

 

For

 

For

 

 

 

9

ERNEST MARIO, PH.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S 2008 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

 


 

4.

 

APPROVAL, BY NON-BINDING VOTE, OF EXECUTIVE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

5.

 

STOCKHOLDER PROPOSAL DESCRIBED IN MORE DETAIL IN THE PROXY STATEMENT.

 

Shareholder

 

Against

 

For

 

 

CERES, INC.

 

Security

156773103

Meeting Type

Annual

Ticker Symbol

CERE

Meeting Date

08-Feb-2013

Record Date

20-Dec-2012

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

RAYMOND DEBBANE

 

 

 

For

 

For

 

 

 

2

ROBERT GOLDBERG

 

 

 

For

 

For

 

 

 

3

THOMAS KILEY

 

 

 

For

 

For

 

 

 

4

STEVEN KOONIN

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY AND APPROVE THE AMENDED AND RESTATED CERES, INC. 2011 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING AUGUST 31, 2013.

 

Management

 

For

 

For

 

 


 

CERES, INC.

 

Security

156773103

Meeting Type

Annual

Ticker Symbol

CERE

Meeting Date

15-Aug-2012

Record Date

09-Jul-2012

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO AMEND THE 2000 STOCK OPTION/STOCK ISSUANCE PLAN TO EXTEND THE TERM OF OUTSTANDING OPTIONS TO PURCHASE 403,666 SHARES OF COMMON STOCK THAT WERE GRANTED UNDER THE 2000 PLAN AND THAT ARE SCHEDULED TO EXPIRE ON DECEMBER 18, 2012 TO THIRTEEN YEARS FROM THEIR DATE OF GRANT.

 

Management

 

For

 

For

 

 


 

COVANCE INC.

 

Security

222816100

Meeting Type

Annual

Ticker Symbol

CVD

Meeting Date

07-May-2013

Record Date

13-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOSEPH L. HERRING

 

 

 

For

 

For

 

 

 

2

JOHN MCCARTNEY

 

 

 

For

 

For

 

 

 

3

B.T. SHEARES, PH.D.

 

 

 

For

 

For

 

2.

 

ADVISORY APPROVAL OF THE COMPANY’S EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

3.

 

APPROVAL OF THE 2013 EMPLOYEE EQUITY PARTICIPATION PLAN.

 

Management

 

For

 

For

 

4.

 

RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP FOR THE FISCAL YEAR 2013.

 

Management

 

For

 

For

 

 

CUBIST PHARMACEUTICALS, INC.

 

Security

229678107

Meeting Type

Annual

Ticker Symbol

CBST

Meeting Date

12-Jun-2013

Record Date

16-Apr-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

MR. MICHAEL BONNEY

 

 

 

For

 

For

 

 

 

2

MARK CORRIGAN, M.D.

 

 

 

For

 

For

 

 

 

3

MS. ALISON LAWTON

 

 

 

For

 

For

 

2.

 

ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

APPROVAL OF THE AMENDMENT TO OUR AMENDED AND RESTATED BY-LAWS TO IMPLEMENT A MAJORITY VOTING STANDARD IN UNCONTESTED ELECTIONS OF DIRECTORS BEGINNING WITH OUR 2014 ANNUAL MEETING OF STOCKHOLDERS.

 

Management

 

For

 

For

 

 


 

4.

 

APPROVAL OF THE AMENDMENT TO OUR AMENDED AND RESTATED BY-LAWS TO MAKE CERTAIN CHANGES RELATED TO CUBIST’S RECENT SEPARATION OF THE ROLES OF CHIEF EXECUTIVE OFFICER AND PRESIDENT.

 

Management

 

For

 

For

 

5.

 

APPROVAL OF THE AMENDMENT TO OUR AMENDED AND RESTATED BY-LAWS TO MAKE CERTAIN CHANGES REGARDING THE CONDUCT OF, AND PROCEDURES FOR, OUR STOCKHOLDER MEETINGS.

 

Management

 

For

 

For

 

6.

 

APPROVAL OF THE AMENDMENT TO OUR RESTATED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

7.

 

RATIFICATION OF OUR SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 

CURIS, INC.

 

Security

231269101

Meeting Type

Annual

Ticker Symbol

CRIS

Meeting Date

30-May-2013

Record Date

01-Apr-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT E. MARTELL

 

 

 

For

 

For

 

 

 

2

DANIEL R. PASSERI

 

 

 

For

 

For

 

 

 

3

MARC RUBIN

 

 

 

For

 

For

 

2.

 

TO APPROVE THE AMENDED AND RESTATED 2010 STOCK INCENTIVE PLAN

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO OUR RESTATED CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

 


 

4.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR

 

Management

 

For

 

For

 

 

CVS CAREMARK CORPORATION

 

Security

126650100

Meeting Type

Annual

Ticker Symbol

CVS

Meeting Date

09-May-2013

Record Date

13-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: C. DAVID BROWN II

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: DAVID W. DORMAN

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: ANNE M. FINUCANE

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: KRISTEN GIBNEY WILLIAMS

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: LARRY J. MERLO

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: JEAN-PIERRE MILLON

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: RICHARD J. SWIFT

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: WILLIAM C. WELDON

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: TONY L. WHITE

 

Management

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY INDEPENDENT PUBLIC ACCOUNTING FIRM FOR 2013.

 

Management

 

For

 

For

 

3.

 

SAY ON PAY - AN ADVISORY VOTE ON THE APPROVAL OF EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

 


 

4.

 

AMEND THE COMPANY’S 2007 EMPLOYEE STOCK PURCHASE PLAN TO ADD SHARES TO THE PLAN.

 

Management

 

For

 

For

 

5.

 

AMEND THE COMPANY’S CHARTER TO REDUCE VOTING THRESHOLDS IN THE FAIR PRICE PROVISION.

 

Management

 

For

 

For

 

6.

 

STOCKHOLDER PROPOSAL REGARDING POLITICAL CONTRIBUTIONS AND EXPENDITURES.

 

Shareholder

 

Against

 

For

 

7.

 

STOCKHOLDER PROPOSAL REGARDING POLICY ON ACCELERATED VESTING OF EQUITY AWARDS UPON A CHANGE IN CONTROL.

 

Shareholder

 

Against

 

For

 

8.

 

STOCKHOLDER PROPOSAL REGARDING LOBBYING EXPENDITURES.

 

Shareholder

 

Against

 

For

 

 

DENDREON CORPORATION

 

Security

24823Q107

Meeting Type

Annual

Ticker Symbol

DNDN

Meeting Date

22-Apr-2013

Record Date

22-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: BOGDAN DZIURZYNSKI, D.P.A.

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: DOUGLAS G. WATSON

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE ADOPTION OF THE DENDREON CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

 


 

3.

 

TO APPROVE THE AMENDMENT TO THE RIGHTS AGREEMENT, DATED AS OF MAY 4, 2012, TO HELP PRESERVE UNDER SECTION 382 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED, THE VALUE OF THE NET OPERATING LOSS CARRYOVERS AND OTHER DEFERRED TAX ASSETS OF THE COMPANY.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

5.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 

EDWARDS LIFESCIENCES CORPORATION

 

Security

28176E108

Meeting Type

Annual

Ticker Symbol

EW

Meeting Date

14-May-2013

Record Date

20-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: ROBERT A. INGRAM

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: WILLIAM J. LINK

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: WESLEY W. VON SCHACK

 

Management

 

For

 

For

 

2.

 

APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE LONG-TERM STOCK INCENTIVE COMPENSATION PROGRAM

 

Management

 

For

 

For

 

3.

 

APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE U.S. EMPLOYEE STOCK PURCHASE PLAN

 

Management

 

For

 

For

 

 


 

4.

 

ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION

 

Management

 

For

 

For

 

5.

 

RATIFICATION OF APPOINTMENT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Management

 

For

 

For

 

6.

 

APPROVAL OF AMENDMENTS TO THE RESTATED CERTIFICATE OF INCORPORATION TO DECLASSIFY THE BOARD

 

Management

 

For

 

For

 

7.

 

APPROVAL OF AN AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION TO ELIMINATE THE SUPERMAJORITY VOTING PROVISION

 

Management

 

For

 

For

 

8.

 

ADVISORY VOTE TO APPROVE THE STOCKHOLDER PROPOSAL REGARDING SPECIAL MEETINGS OF STOCKHOLDERS

 

Shareholder

 

Against

 

For

 

 

ELAN CORPORATION, PLC

 

Security

284131208

Meeting Type

Annual

Ticker Symbol

ELN

Meeting Date

30-May-2013

Record Date

29-Apr-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

O1

 

TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS, DIRECTORS REPORT AND AUDITORS REPORT FOR THE YEAR ENDED 31 DECEMBER 2012.

 

Management

 

For

 

N/A

 

O2

 

TO RECEIVE AND CONSIDER THE REPORT BY THE LEADERSHIP, DEVELOPMENT AND COMPENSATION COMMITTEE FOR THE YEAR ENDED 31 DECEMBER 2012.

 

Management

 

For

 

N/A

 

O3A

 

TO RE-ELECT MR. ROBERT INGRAM.

 

Management

 

For

 

N/A

 

O3B

 

TO RE-ELECT MR. GARY KENNEDY.

 

Management

 

For

 

N/A

 

O3C

 

TO RE-ELECT MR. PATRICK KENNEDY.

 

Management

 

For

 

N/A

 

 


 

O3D

 

TO RE-ELECT MR. KELLY MARTIN.

 

Management

 

For

 

N/A

 

O3E

 

TO RE-ELECT MR. KIERAN MCGOWAN.

 

Management

 

For

 

N/A

 

O3F

 

TO RE-ELECT MR. KYRAN MCLAUGHLIN.

 

Management

 

For

 

N/A

 

O3G

 

TO RE-ELECT MR. DONAL O’CONNOR.

 

Management

 

For

 

N/A

 

O3H

 

TO RE-ELECT MR. RICHARD PILNIK.

 

Management

 

For

 

N/A

 

O3I

 

TO RE-ELECT DR. ANDREW VON ESCHENBACH.

 

Management

 

For

 

N/A

 

O4

 

TO AUTHORISE THE DIRECTORS TO FIX THE REMUNERATION OF THE AUDITORS.

 

Management

 

For

 

N/A

 

O5

 

TO AUTHORISE THE DIRECTORS TO ALLOT AND ISSUE RELEVANT SECURITIES.

 

Management

 

For

 

N/A

 

S6

 

TO AUTHORISE THE DISAPPLICATION OF PRE-EMPTION RIGHTS.

 

Management

 

For

 

N/A

 

S7

 

TO REDUCE THE AUTHORISED BUT UN- ISSUED SHARE CAPITAL OF THE COMPANY, REGARDING THE “B” EXECUTIVE AND NON- VOTING EXECUTIVE SHARES, AND AMEND THE MEMORANDUM & ARTICLES OF ASSOCIATION ACCORDINGLY.

 

Management

 

For

 

N/A

 

S8

 

TO AUTHORISE THE COMPANY TO MAKE MARKET PURCHASES OF ITS OWN SHARES.

 

Management

 

For

 

N/A

 

S9

 

TO SET THE RE-ISSUE PRICE RANGE FOR TREASURY SHARES.

 

Management

 

For

 

N/A

 

S10

 

TO RETAIN A 14 DAY NOTICE PERIOD FOR EXTRAORDINARY GENERAL MEETINGS.

 

Management

 

For

 

N/A

 

 


 

ELAN CORPORATION, PLC

 

Security

284131208

Meeting Type

Contested-Special

Ticker Symbol

ELN

Meeting Date

17-Jun-2013

Record Date

23-May-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO AUTHORIZE THE COMPANY TO ENTER INTO THE THERAVANCE TRANSACTION AS SET OUT IN THE CIRCULAR TO ELAN SHAREHOLDERS DATED 24 MAY 2013.

 

Management

 

For

 

For

 

2.

 

TO AUTHORIZE THE COMPANY TO ENTER INTO THE AOP TRANSACTION AS SET OUT IN THE CIRCULAR TO ELAN SHAREHOLDERS DATED 24 MAY 2013.

 

Management

 

For

 

For

 

3.

 

TO AUTHORIZE THE COMPANY TO ENTER INTO THE ELND005 TRANSACTION AS SET OUT IN THE CIRCULAR TO ELAN SHAREHOLDERS DATED 24 MAY 2013.

 

Management

 

For

 

For

 

4.

 

TO AUTHORIZE THE COMPANY TO ENTER INTO THE SHARE REPURCHASE PROGRAM AS SET OUT IN THE CIRCULAR TO ELAN SHAREHOLDERS DATED 24 MAY 2013.

 

Management

 

For

 

For

 

 

ENDO HEALTH SOLUTIONS INC.

 

Security

29264F205

Meeting Type

Annual

Ticker Symbol

ENDP

Meeting Date

22-May-2013

Record Date

01-Apr-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: ROGER H. KIMMEL

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: RAJIV DE SILVA

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: JOHN J. DELUCCA

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: NANCY J. HUTSON, PH.D.

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: MICHAEL HYATT

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: WILLIAM P. MONTAGUE

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: DAVID B. NASH, M.D., M.B.A.

 

Management

 

For

 

For

 

 


 

1H.

 

ELECTION OF DIRECTOR: JOSEPH C. SCODARI

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: JILL D. SMITH

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: WILLIAM F. SPENGLER

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, BY ADVISORY VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

 

EUTHYMICS BIOSCIENCES, INC.

 

Security

N/A

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

Meeting Date

19-Nov-2012

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

GENERAL MATTERS.

 

Management

 

For

 

For

 

2.

 

ADOPT AND APPROVE THE SEVENTH AMENDED AND RESTARTED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

3.

 

APPROVE THE AMENDMENT TO THE 2010 EQUITY INCENTIVE PLAN INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE TO 5,989,667.

 

Management

 

For

 

For

 

 

GEN-PROBE INCORPORATED

 

Security

36866T103

Meeting Type

Special

Ticker Symbol

GPRO

Meeting Date

31-Jul-2012

Record Date

29-Jun-2012

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

PROPOSAL TO ADOPT THE AGREEMENT AND PLAN OF MERGER BY AND AMONG GEN-PROBE INCORPORATED, HOLOGIC, INC. AND GOLD ACQUISITION CORP., AS IT MAY BE AMENDED FROM TIME TO TIME (THE “AGREEMENT AND PLAN OF MERGER”).

 

Management

 

For

 

For

 

2.

 

PROPOSAL TO ADJOURN THE SPECIAL MEETING TO A LATER DATE TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES TO APPROVE PROPOSAL 1 AT THE TIME OF THE SPECIAL MEETING.

 

Management

 

For

 

For

 

 


 

3.

 

PROPOSAL TO APPROVE, ON A NON- BINDING ADVISORY BASIS, CERTAIN COMPENSATION ARRANGEMENTS FOR GEN-PROBE INCORPORATED’S NAMED EXECUTIVE OFFICERS IN CONNECTION WITH THE AGREEMENT AND PLAN OF MERGER.

 

Management

 

For

 

For

 

 

GILEAD SCIENCES, INC.

 

Security

375558103

Meeting Type

Annual

Ticker Symbol

GILD

Meeting Date

08-May-2013

Record Date

13-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOHN F. COGAN

 

 

 

For

 

For

 

 

 

2

ETIENNE F. DAVIGNON

 

 

 

For

 

For

 

 

 

3

CARLA A. HILLS

 

 

 

For

 

For

 

 

 

4

KEVIN E. LOFTON

 

 

 

For

 

For

 

 

 

5

JOHN W. MADIGAN

 

 

 

For

 

For

 

 

 

6

JOHN C. MARTIN

 

 

 

For

 

For

 

 

 

7

NICHOLAS G. MOORE

 

 

 

For

 

For

 

 

 

8

RICHARD J. WHITLEY

 

 

 

For

 

For

 

 

 

9

GAYLE E. WILSON

 

 

 

For

 

For

 

 

 

10

PER WOLD-OLSEN

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

TO APPROVE A RESTATEMENT OF GILEAD SCIENCES, INC.’S 2004 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

 


 

4.

 

TO APPROVE AN AMENDMENT TO GILEAD’S RESTATED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

5.

 

TO APPROVE, ON THE ADVISORY BASIS, THE COMPENSATION OF GILEAD’S NAMED EXECUTIVE OFFICERS AS PRESENTED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

6.

 

TO VOTE ON A STOCKHOLDER PROPOSAL REQUESTING THAT THE BOARD ADOPT A POLICY THAT THE CHAIRMAN OF THE BOARD OF DIRECTORS BE AN INDEPENDENT DIRECTOR, IF PROPERLY PRESENTED AT THE MEETING.

 

Shareholder

 

For

 

Against

 

7.

 

TO VOTE ON A STOCKHOLDER PROPOSAL REQUESTING THAT THE BOARD TAKE STEPS TO PERMIT STOCKHOLDER ACTION BY WRITTEN CONSENT, IF PROPERLY PRESENTED AT THE MEETING.

 

Shareholder

 

Against

 

For

 

 

HOLOGIC, INC.

 

Security

436440101

Meeting Type

Annual

Ticker Symbol

HOLX

Meeting Date

11-Mar-2013

Record Date

11-Jan-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DAVID R. LAVANCE, JR.

 

 

 

For

 

For

 

 

 

2

ROBERT A. CASCELLA

 

 

 

For

 

For

 

 

 

3

GLENN P. MUIR

 

 

 

For

 

For

 

 

 

4

SALLY W. CRAWFORD

 

 

 

For

 

For

 

 

 

5

NANCY L. LEAMING

 

 

 

For

 

For

 

 

 

6

LAWRENCE M. LEVY

 

 

 

For

 

For

 

 

 

7

CHRISTIANA STAMOULIS

 

 

 

For

 

For

 

 

 

8

ELAINE S. ULLIAN

 

 

 

For

 

For

 

 


 

 

 

9

WAYNE WILSON

 

 

 

For

 

For

 

2.

 

TO APPROVE THE HOLOGIC, INC. AMENDED AND RESTATED 2008 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

A NON-BINDING ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

 

IDEXX LABORATORIES, INC.

 

Security

45168D104

Meeting Type

Annual

Ticker Symbol

IDXX

Meeting Date

08-May-2013

Record Date

11-Mar-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JONATHAN W. AYERS

 

 

 

For

 

For

 

 

 

2

ROBERT J. MURRAY

 

 

 

For

 

For

 

 

 

3

M. ANNE SZOSTAK

 

 

 

For

 

For

 

2.

 

ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. TO APPROVE A NONBINDING ADVISORY RESOLUTION ON THE COMPANY’S EXECUTIVE COMPENSATION PROGRAM.

 

Management

 

For

 

For

 

3.

 

AMENDMENTS TO IDEXX LABORATORIES, INC. 2009 STOCK INCENTIVE PLAN. TO APPROVE PROPOSED AMENDMENTS TO OUR 2009 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

 


 

4.

 

RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR.

 

Management

 

For

 

For

 

 

ILLUMINA, INC.

 

Security

452327109

Meeting Type

Annual

Ticker Symbol

ILMN

Meeting Date

29-May-2013

Record Date

02-Apr-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

GERALD MOLLER, PH.D.*

 

 

 

For

 

For

 

 

 

2

DAVID R. WALT, PH.D.*

 

 

 

For

 

For

 

 

 

3

R.S. EPSTEIN, M.D.#

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 29, 2013

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT

 

Management

 

For

 

For

 

4.

 

TO APPROVE AN AMENDMENT TO THE ILLUMINA, INC. 2005 STOCK AND INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE BY 5,000,000 SHARES AND TO EXTEND THE TERMINATION DATE OF THE PLAN UNTIL JUNE 28, 2016

 

Management

 

For

 

For

 

 

 


 

IMMUNOGEN, INC.

 

Security

45253H101

Meeting Type

Annual

Ticker Symbol

IMGN

Meeting Date

13-Nov-2012

Record Date

18-Sep-2012

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO FIX THE NUMBER OF MEMBERS OF THE BOARD OF DIRECTORS AT TEN (10).

 

Management

 

For

 

For

 

2.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

MARK SKALETSKY

 

 

 

For

 

For

 

 

 

2

J. J. VILLAFRANCA PH.D.

 

 

 

For

 

For

 

 

 

3

NICOLE ONETTO, MD

 

 

 

For

 

For

 

 

 

4

STEPHEN C. MCCLUSKI